1.Sridhar, S, Lau, SK and Woo, PC (2015) Hepatitis E: a disease of reemerging importance. Journal of the Formosan Medical Association 114, 681–690.
2.Nimgaonkar, I et al. (2018) Hepatitis E virus: advances and challenges. Nature Reviews Gastroenterology & Hepatology 15, 96–110.
3.The European Association for the Study of the Liver (2018) EASL clinical practice guidelines on hepatitis E virus infection. Journal of Hepatology 68, 1256–1271.
4.Sridhar, S et al. (2017) Hepatitis E virus genotypes and evolution: emergence of camel hepatitis E variants. International Journal of Molecular Sciences 18, E869.
5.Woo, PC et al. (2014) New hepatitis E virus genotype in camels, the Middle East. Emerging Infectious Diseases 20, 1044–1048.
6.Lee, GH et al. (2016) Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology 150, 355–357, e3.
7.Obaidat, MM and Roess, AA (2018) Seroprevalence and risk factors of hepatitis E infection in Jordan's population: first report. International Journal of Infectious Diseases 66, 121–125.
8.Faber, M et al. (2018) Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population. Journal of Viral Hepatitis 25, 752–758.
9.Grabarczyk, P et al. (2018) Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland. Transfusion 58, 1245–1253.
10.Hewitt, J et al. (2018) Prevalence of hepatitis E virus antibodies and infection in New Zealand blood donors. New Zealand Medical Journal 131, 38–43.
11.Nascimento, MSJ et al. (2018) A nationwide serosurvey of hepatitis E virus antibodies in the general population of Portugal. The European Journal of Public Health 28, 720–724.
12.Lopes, T et al. (2017) Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype? Epidemiology and Infection 145, 1910–1912.
13.Campolmi, I et al. (2018) Seroprevalence of hepatitis A virus, hepatitis E virus, and Helicobacter pylori in rural communities of the Bolivian Chaco, 2013. The American Journal of Tropical Medicine and Hygiene 98, 1275–1280.
14.Farshadpour, F et al. (2018) Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. PLoS ONE 13, e0191090.
15.Cai, Y et al. (2017) Seroprevalence and risk factors of hepatitis E virus infection among the Korean, Manchu, Mongol, and Han ethnic groups in Eastern and Northeastern China. Journal of Medical Virology 89, 1988–1994.
16.Greco, L et al. (2018) HEV and HAV seroprevalence in men that have sex with men (MSM): an update from Milan, Italy. Journal of Medical Virology 90, 1323–1327.
17.Slot, E et al. (2017) Meat consumption is a major risk factor for hepatitis E virus infection. PLoS ONE 12, e0176414.
18.Bura, M et al. (2017) Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland. International Journal of Infectious Diseases 61, 20–22.
19.Heil, J et al. (2018) Hepatitis E prevalence in a sexual high-risk population compared to the general population. PLoS ONE 13, e0191798.
20.Bricks, G et al. (2018) Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil. Brazilian Journal of Infectious Diseases 22, 85–91.
21.Mor, O et al. (2015) Prevalence of hepatitis E virus antibodies, Israel, 2009–2010. Emerging Infectious Diseases 21, 692–694.
22.Jahanbakhsh, F et al. (2017) Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis among sheltered homeless adults in Tehran, 2012. International Journal of Health Policy and Management 7, 225–230.
23.Moor, D et al. (2018) Screening of ready-to-eat meat products for hepatitis E virus in Switzerland. Food and Environmental Virology 10, 263–271.
24.Gallian, P et al. (2014) Hepatitis E virus infections in blood donors, France. Emerging Infectious Diseases 20, 1914–1917.
25.Faber, MS et al. (2012) Hepatitis E virus seroprevalence among adults, Germany. Emerging Infectious Diseases. 18, 1654–1657.
27.Shimol, SB et al. (2012) Human brucellosis outbreak acquired through camel milk ingestion in southern Israel. Israel Medical Association Journal 14, 475–478.
31.Li, TC et al. (2017) Serological evidence of hepatitis E virus infection in dromedary camels in Ethiopia. Journal of Virological Methods 246, 34–37.
32.Rasche, A et al. (2016) Hepatitis E virus infection in dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983–2015. Emerging Infectious Diseases 22, 1249–1252.
33.Boon, D et al. (2018) Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda. Journal of Infectious Diseases 217, 785–789.
34.Cattoir, L et al. (2018) Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium. Journal of Clinical Virology 103, 8–11.
35.Karbalaie Niya, MH et al. (2017) Hepatitis E virus seroprevalence rate among Eastern Mediterranean and middle eastern countries; A systematic review and pooled analysis. Microbial Pathogenesis 110, 252–256.
36.Thom, K et al. (2018) Hepatitis E virus (HEV) in Scotland: evidence of recent increase in viral circulation in humans. Eurosurveillance 23, pii=17-00174.
37.Löve, A et al. (2018) Low prevalence of hepatitis E in Iceland: a seroepidemiological study. Scandinavian Journal of Gastroenterology 53, 293–296.
38.Forni, D et al. (2018) Origin and dispersal of hepatitis E virus. Emerging Microbes and Infections 7, 11.
39.Ram, D et al. (2016) Hepatitis E virus genotype 3 in sewage and genotype 1 in acute hepatitis cases, Israel. American Journal of Tropical Medicine and Hygiene 95, 216–220.
40.Al-Sadeq, DW et al. (2018) Laboratory challenges in the diagnosis of hepatitis E virus. Journal of Medical Microbiology 67, 466–480.